Wednesday, December 11, 2013
Friday, October 18, 2013
Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division.
In the Lab
Monday, September 9, 2013
Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable.
In the Clinic
Thursday, August 22, 2013
An international study led by Memorial Sloan Kettering found that pazopanib (Votrient®) controls cancer as effectively as sunitinib (Sutent®) while improving patients’ quality of life.